Molecular Diagnostics and Serology Testing

This contract involves performing molecular diagnostics, including PCR and RT-PCR, as well as serology testing on clinical specimens to detect various viral infections such as dengue, chikungunya, Zika, hantavirus, and Crimean-Congo Hemorrhagic Fever (CCHF). The work focuses on advanced laboratory techniques to accurately identify these pathogens, supporting public health and research efforts related to infectious diseases. The contract is issued as a subcontract under the NAICS code 541380, which corresponds to testing laboratories. The contract is managed by the Naval Medical Research Center, a division of the Department of Defense, and the testing is to be conducted in Silver Spring, Maryland. The solicitation was posted on May 5, 2026, with responses due by May 10, 2026. This short turnaround indicates a priority for timely engagement, likely reflecting the critical nature of the diagnostic testing. No specific set-aside type or organization type is indicated, and while contact details were not provided, the official workspace link for the contract offers further access to information.